Blog

Posted: 27 august 2025

Study identifies molecular pathway that drives advanced prostate cancer

University of Kentucky Markey Cancer Center researchers have identified a cellular pathway that fuels the progression of aggressive, drug-resistant prostate cancer. Read more here.

Akeso says its closely watched drug improved patient survival in a lung cancer trial

Akeso, a Chinese biotech with a drug positioned to rival Merck’s megablockbuster Keytruda, has reported for the first time that the therapy can improve patient survival. Read more here.

Tempus AI acquires Paige for $81M

AI-powered data company Tempus AI announced it will acquire Paige, an AI-enabled diagnostic platform for oncologists and pathologists, for $81.25 million. Read more here.

Waystar makes $1.25B bet on AI for healthcare payments

Waystar has signed a definitive agreement to acquire Iodine Software, a $1.25 billion deal that seeks to empower healthcare payments with more AI capabilities. Read more here.

NICE approves new treatment for inflammatory bowel disease

Doctors will be able to prescribe a new treatment for people with inflammatory bowel disease (IBD), after the UK medicines watchdog approved guselkumab (Tremfya) for use on the NHS. Read more here.

Scientists discover eight new schizophrenia genes

The breakthrough, made by scientists at the Centre for Neuropsychiatric Genetics and Genomics (CNGG) at Cardiff University, provides new information and improves the understanding and future treatment development for schizophrenia. Read more here.

Quarter of junior doctors work part-time

In a survey of 50,000 junior doctors, now officially known as resident doctors, 24 per cent said they opted to work “less than full-time”. The average full-time hours are 40 to 48 hours per week. Read more here.

WY ICB Distinguished Lecture Series - The Future of Digital Health

Health Innovation Yorkshire & Humber are proud to launch the Distinguished Lecture Series - as part of the Digital, Data, Technology and AI Literacy Programme, a partnership between @WYPartnership and West Yorkshire Innovation Hub. Date: Mon 22 Sept, 12:00 pm. Read…

Avoiding Pitfalls in Healthcare Capital Planning

Capital planning in healthcare is not merely an administrative obligation—it is a strategic discipline that shapes clinical capabilities, operational resilience and financial health. Recognising and addressing common planning mistakes is essential to sustaining high-quality, efficient care in an increasingly complex…

Bye bye, bifocals? New eye drops can fix farsightedness

The US Food and Drug Administration has approved the first eye drop that could allow users to ditch their bifocals—or at least rely on them far less often. Developed by the pharmaceutical company LENZ, VIZZ is an aceclidine ophthalmic treatment in the form of…

Gates Foundation pledges $2.5B to women’s health research

The Gates Foundation said it is committing to invest $2.5 billion over the next five years to accelerate research and development in neglected areas of women’s health. Lack of investment often slows the research necessary for biotechnology companies to develop new medicines,…

OpenAI's Sam Altman touts benefit of GPT-5 for healthcare

OpenAI released its most advanced reasoning model, GPT-5, which it touts as its most useful model for healthcare. Read more here.

Get Involved

On the day